Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Clancy

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Pediatric Pulmonology|February 13, 2023
Built environment factors predictive of early rapid lung function decline in cystic fibrosisEmrah Gecili, Cole Brokamp, Erika Rasnick, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 24, 2018
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosisIsabelle Sermet-Gaudelus, John P Clancy, David P Nichols, et al.
The Lancet. Respiratory Medicine|August 2, 2025
Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trialsNicole Mayer-Hamblett, Natanya R Kerper, John P Clancy, et al.
Human Gene Therapy|August 10, 2007
Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trialRichard B Moss, Carlos Milla, John Colombo, et al.
Annals of the American Thoracic Society|January 19, 2021
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study DesignNicole Mayer-Hamblett, David P Nichols, Katherine Odem-Davis, et al.
Pediatric Research|June 23, 2009
Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe diseasePriya S Kishnani, Deya Corzo, Nancy D Leslie, et al.
American Journal of Respiratory and Critical Care Medicine|April 25, 2018
Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical TrialScott D Sagel, Umer Khan, Raksha Jain, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2020
Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic FibrosisAaron I Gardner, Iram J Haq, A John Simpson, et al.
Plos One|September 17, 2013
Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR functionJohn P Clancy, Rhonda D Szczesniak, Melissa A Ashlock, et al.
The European Respiratory Journal|November 18, 2017
Airway microbiota across age and disease spectrum in cystic fibrosisEdith T Zemanick, Brandie D Wagner, Charles E Robertson, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Pediatric Pulmonology|February 13, 2023
Built environment factors predictive of early rapid lung function decline in cystic fibrosisEmrah Gecili, Cole Brokamp, Erika Rasnick, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 24, 2018
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosisIsabelle Sermet-Gaudelus, John P Clancy, David P Nichols, et al.
The Lancet. Respiratory Medicine|August 2, 2025
Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trialsNicole Mayer-Hamblett, Natanya R Kerper, John P Clancy, et al.
Human Gene Therapy|August 10, 2007
Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trialRichard B Moss, Carlos Milla, John Colombo, et al.
Annals of the American Thoracic Society|January 19, 2021
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study DesignNicole Mayer-Hamblett, David P Nichols, Katherine Odem-Davis, et al.
Pediatric Research|June 23, 2009
Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe diseasePriya S Kishnani, Deya Corzo, Nancy D Leslie, et al.
American Journal of Respiratory and Critical Care Medicine|April 25, 2018
Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical TrialScott D Sagel, Umer Khan, Raksha Jain, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2020
Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic FibrosisAaron I Gardner, Iram J Haq, A John Simpson, et al.
Plos One|September 17, 2013
Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR functionJohn P Clancy, Rhonda D Szczesniak, Melissa A Ashlock, et al.
The European Respiratory Journal|November 18, 2017
Airway microbiota across age and disease spectrum in cystic fibrosisEdith T Zemanick, Brandie D Wagner, Charles E Robertson, et al.
Pageof 13